Key Takeaways
- • .406 Ventures reaches 20-year milestone with $1.3 billion raised across five core funds and three opportunity funds, backed by six unicorn exits over two decades.
- • Firm announces 100th portfolio investment in Teal Health, a women's healthcare company, marking a significant expansion of its early-stage investment footprint.
- • Kathryn Taylor Reddy promoted to Partner from Principal, reflecting internal advancement and team expansion as the firm scales operations.
- • Most recent fund raise of $265 million (Point 406 Ventures V) already deployed to four companies, including Portrait Analytics, a generative AI developer, signaling continued focus on data + AI alongside healthcare and cybersecurity verticals.
- • Portfolio strategy focuses on three core sectors: healthcare, data + AI, and cybersecurity, positioning the firm within high-growth, mission-critical technology markets.
Summary
.406 Ventures, a Boston-based early-stage venture capital firm, marked its 20th anniversary on September 22, 2026, by announcing its 100th portfolio investment and a significant organizational promotion. The firm invested in Teal Health, a women's healthcare company, as part of the milestone celebration. Over two decades, .406 Ventures has accumulated substantial scale, having raised more than $1.3 billion in capital commitments across five core funds and three opportunity funds, and has backed six unicorn companies during that period.
The firm's investment strategy concentrates on three primary sectors: healthcare, data + AI, and cybersecurity. This focused approach has enabled .406 to develop specialized expertise and relationships within these high-growth verticals. The 100th investment in Teal Health aligns with the firm's healthcare thesis and reflects continued momentum in early-stage deployment despite broader market conditions.
Internally, the firm promoted Kathryn Taylor Reddy from Principal to Partner, signaling organizational maturation and investment in senior leadership talent. Co-founder and Managing Partner Liam Donohue contextualized the milestone as a collective achievement, stating, "This milestone belongs to the entire .406 network," acknowledging the contributions of portfolio founders, limited partners, and the extended ecosystem that supported the firm's growth trajectory.
The firm's most recent fund raise—Point 406 Ventures V at $265 million—has already begun active deployment, with four investments already announced from that vehicle, including Portrait Analytics, a generative AI company. This deployment velocity demonstrates continued institutional confidence in the firm's deal sourcing and value-creation capabilities in emerging technology categories. The combination of substantial assets under management, sector specialization, and proven exit track record positions .406 Ventures as a consistent player in early-stage venture financing for institutional and family office allocators seeking exposure to healthcare innovation and AI-driven software platforms.
The firm's investment strategy concentrates on three primary sectors: healthcare, data + AI, and cybersecurity. This focused approach has enabled .406 to develop specialized expertise and relationships within these high-growth verticals. The 100th investment in Teal Health aligns with the firm's healthcare thesis and reflects continued momentum in early-stage deployment despite broader market conditions.
Internally, the firm promoted Kathryn Taylor Reddy from Principal to Partner, signaling organizational maturation and investment in senior leadership talent. Co-founder and Managing Partner Liam Donohue contextualized the milestone as a collective achievement, stating, "This milestone belongs to the entire .406 network," acknowledging the contributions of portfolio founders, limited partners, and the extended ecosystem that supported the firm's growth trajectory.
The firm's most recent fund raise—Point 406 Ventures V at $265 million—has already begun active deployment, with four investments already announced from that vehicle, including Portrait Analytics, a generative AI company. This deployment velocity demonstrates continued institutional confidence in the firm's deal sourcing and value-creation capabilities in emerging technology categories. The combination of substantial assets under management, sector specialization, and proven exit track record positions .406 Ventures as a consistent player in early-stage venture financing for institutional and family office allocators seeking exposure to healthcare innovation and AI-driven software platforms.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.